StockUK listing UKAOTILSEHealthcareProfitless Growth

AOTI Inc(AOTI) Stock Analysis | Healthcare

GBX --+0.00%
Reward68High
Risk78High
75%Data
Thin 5% profit margin · Revenue growing 11% YoY
GBX —+0.00 (+0.00%) Previous close · LSE
Market cap 140.59M
Reward Ratingⓘ68 High reward assessment · 75% data coverage
Top 25% of stocksView factors
Risk Ratingⓘ78 High risk assessment
Risk factors availableUnlock details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on AOTI to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available yet for this stock
The overview tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Earnings Ex-dividend

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is AOTI Inc?

, together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide.

AI Brief Pro

The brief on AOTI Inc

The story behind the price, the case for and against, and what could go wrong. Open a part to read it.

What is AOTI Inc?

, together with its subsidiaries, patents, manufacturers, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, a negative pressure disposable wound therapy system for use in home, acute and extended care settings. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 140.59M, and a P/E ratio of 66.3x.

Financial Highlights

Investment Breakdown

Growth
Revenue and earnings growing steadily, indicating improving operating performance.
Profitability
Adequate profitability with some margin variability in recent periods.
Risk
Elevated volatility implies higher downside and expectation risk.
Valuation
Premium valuation reflects strong growth expectations already priced in.

OpenBook Logo Analysis

Reward: High (68)

Similar stocks to compare

A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.

All Healthcare stocks →
Company Information
IndustryMedical Devices
Market Cap140.59M
Beta2.906
Insider Activity
12M windowAwaiting coverage
LSE director-dealings coverage launching later this year. The data feed is in development.